Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.540
+0.035 (1.00%)
At close: Mar 6, 2026, 4:00 PM EST
3.636
+0.096 (2.70%)
After-hours: Mar 6, 2026, 7:59 PM EST
Altimmune Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.04 | 0.02 | 0.43 | -0.07 | 4.41 | |
| Revenue Growth (YoY) | 105.00% | -95.30% | - | - | -46.12% | |
| Cost of Revenue | 66.43 | 82.23 | 65.8 | 70.45 | 73.84 | |
| Gross Profit | -66.39 | -82.21 | -65.37 | -70.52 | -69.43 | |
| Selling, General & Admin | 28.1 | 20.97 | 18.14 | 17.13 | 15.41 | |
| Operating Expenses | 28.1 | 20.97 | 18.14 | 17.13 | 15.41 | |
| Operating Income | -94.49 | -103.17 | -83.51 | -87.65 | -84.84 | |
| Interest Expense | -1.64 | -0.01 | -0.04 | -0.01 | -0.01 | |
| Interest & Investment Income | 7.54 | 8.07 | 7.35 | 2.87 | 0.2 | |
| Other Non Operating Income (Expenses) | -0.19 | 0.05 | 0.17 | -0.03 | -0.37 | |
| EBT Excluding Unusual Items | -88.77 | -95.06 | -76.03 | -84.82 | -85.02 | |
| Asset Writedown | - | - | -12.42 | - | -11.37 | |
| Other Unusual Items | - | - | - | -0.09 | -0.7 | |
| Pretax Income | -88.77 | -95.06 | -88.45 | -84.91 | -97.09 | |
| Income Tax Expense | -0.68 | - | - | -0.2 | - | |
| Net Income | -88.09 | -95.06 | -88.45 | -84.71 | -97.09 | |
| Net Income to Common | -88.09 | -95.06 | -88.45 | -84.71 | -97.09 | |
| Shares Outstanding (Basic) | 88 | 71 | 53 | 47 | 41 | |
| Shares Outstanding (Diluted) | 88 | 71 | 53 | 47 | 41 | |
| Shares Change (YoY) | 24.08% | 33.35% | 13.47% | 13.67% | 61.03% | |
| EPS (Basic) | -1.00 | -1.34 | -1.66 | -1.81 | -2.35 | |
| EPS (Diluted) | -1.00 | -1.34 | -1.66 | -1.81 | -2.35 | |
| Free Cash Flow | -67.55 | -79.85 | -75.86 | -62.71 | -90.36 | |
| Free Cash Flow Per Share | -0.77 | -1.13 | -1.43 | -1.34 | -2.19 | |
| Operating Margin | -230460.98% | -515860.00% | -19603.29% | - | -1923.90% | |
| Profit Margin | -214860.98% | -475295.00% | -20762.21% | - | -2201.59% | |
| Free Cash Flow Margin | -164746.34% | -399240.00% | -17806.81% | - | -2048.87% | |
| EBITDA | -94.38 | -102.93 | -83.03 | -87.16 | -84.29 | |
| D&A For EBITDA | 0.11 | 0.24 | 0.48 | 0.49 | 0.55 | |
| EBIT | -94.49 | -103.17 | -83.51 | -87.65 | -84.84 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.